EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy

Robyn-Brooke Labuschagne Naidoo, Helen C Steel iD, Annette J Theron, Ronald Anderson iD, Gregory R Tintinger, Theresa M Rossouw iD

Pathogens · 2024

DOI: 10.3390/pathogens13070540 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pathogens, 2024. Verfasst von Robyn-Brooke Labuschagne Naidoo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Faculty of Health Sciences, University of Pretoria and Steve Biko Academic Hospital, Pretoria 00…. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Increasing drug resistance and the absence of a cure necessitates exploration of novel treatment strategies for people living with HIV (PLWH). Targeting of soluble co-inhibitory immune checkpoint molecules (sICMs) represents a novel, potentially effective strategy in the management of HIV.

Methods

In this retrospective, longitudinal, observational study, the plasma levels of five prominent co-inhibitory sICMs—CTLA-4, LAG-3, PD-1 and its ligand PD-L1, as well as TIM-3—were quantified in 68 PLWH—before and one year after antiretroviral therapy (ART)—and compared with those of 15 healthy control participants.

Results

Relative to control participants, PLWH had substantially elevated pre-treatment levels of all five co-inhibitory sICMs (p < 0.0001–p < 0.0657), which, over the 12-month period of ART, remained significantly higher than those of controls (p < 0.0367–p < 0.0001). PLWH with advanced disease, reflected by a CD4+ T cell count

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHumansMaleFemaleRetrospective StudiesAdultMiddle AgedLongitudinal StudiesImmune Checkpoint ProteinsHepatitis A Virus Cellular Receptor 2Antigens, CDLymphocyte Activation Gene 3 ProteinProgrammed Cell Death 1 ReceptorCTLA-4 AntigenAnti-Retroviral AgentsB7-H1 Antigen

Stichwörter der Autor:innen

CTLA-4HIVLAG-3PD-1PD-L1TIM-3antiretroviral treatmentco-inhibitory immune checkpoints

Substanzen

Immune Checkpoint ProteinsHepatitis A Virus Cellular Receptor 2HAVCR2 protein, humanAntigens, CDLymphocyte Activation Gene 3 ProteinCTLA4 protein, humanProgrammed Cell Death 1 ReceptorCTLA-4 AntigenLag3 protein, humanAnti-Retroviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, Faculty of Health Sciences, University of Pretoria and Steve Biko Academic Hospital, Pretoria 0002, South Africa.
  • Department of Immunology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa.

ORCID-Profile: Helen C Steel, Ronald Anderson, Theresa M Rossouw

Zitieren

APA

Labuschagne Naidoo, R. B., Steel, H. C., Theron, A. J., Anderson, R., Tintinger, G. R., & Rossouw, T. M. (2024). Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy. Pathogens. https://doi.org/10.3390/pathogens13070540

Vancouver

Labuschagne Naidoo RB, Steel HC, Theron AJ, Anderson R, Tintinger GR, Rossouw TM. Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy. Pathogens. 2024. doi:10.3390/pathogens13070540

BibTeX
@article{LabuschagneNaidoo2024,
  author = {Labuschagne Naidoo, Robyn-Brooke and Steel, Helen C and Theron, Annette J and Anderson, Ronald and Tintinger, Gregory R and Rossouw, Theresa M},
  title = {Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13070540}
}
Kostenlos starten →